The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Try the newly designed Company Pages!
Switch now

Abiomed

  • ABMD
  • NASDAQ
  • Consumer Products
  • Latest 26.07
  • Currency US$
  • Change 0.04
  • Percent Change 0.154 %
  • Volume 180,707
  • Thu Aug 28, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
  • Open 25.94
  • Previous Close 26.03
  • High 26.13
  • Low 25.79
  • Bidx0 0.0000
  • Askx0 0.0000
  • 52-week High01/10 30.77
  • 52-week Low09/27 18.15
  • Beta 1.706
  • Market Cap 1,038.11M
  • EPS 0.19
  • P/E 137.211
  • Forward P/E 57.93
  • PEG 10.25
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $183,640,000
  • Earnings $7,350,000
  • Return on Equity 4.47%

Cash Flow

  • Cash Flow --
  • Cash $20,910,000
  • Current Ratio 3.88

12 months ended Dec 31, 2013.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $205,400,000
  • Liabilities $37,050,000
  • Liabilities-to-Equity Ratio 0.22

Price Ratios

  • Price to Sales 5.65
  • Price to Book 6.17
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Jul 31 $0.02 Nov 5 $0.02
Surprises Jul 31 -300.00% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Aug 28, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Abiomed, Inc. is a developer, manufacturer and marketer of medical products designed to safely and effectively assist or replace the pumping function of the failing heart. The company currently manufactures and sells the BVS-5000, a temporary heart assist device, which is approved by the U.S. Food and Drug Administration for the temporary treatment of all patients with failing but potentially recoverable hearts. The company is also engaged in research and development relating to other devices to support the pumping function of the heart.

Related Securities
Symbol Type Latest % Chg

Officers

  • Michael R. Minogue President; C.E.O.; President &
  • Robert L. Bowen Vice President; Chief Financia
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

22 CHERRY HILL DR
DANVERS, MA
01923

Phone: (978)-777-5410
Fax: (978)-7778411

amaillett@abiomed.com
www.abiomed.com

Ideas & Discussion

Live Discussion of ABMD on StockTwits
The Globe and Mail has
updated our Company Pages
Switch to the newly designed Company Pages format today for a more in-depth look at the companies you're following and pages that are easier to navigate. If you prefer the old layout after trying the new Company Pages, you can switch back anytime.